335 related articles for article (PubMed ID: 17961973)
1. First steps in establishing a developmental toxicity test method based on human embryonic stem cells.
Adler S; Pellizzer C; Hareng L; Hartung T; Bremer S
Toxicol In Vitro; 2008 Feb; 22(1):200-11. PubMed ID: 17961973
[TBL] [Abstract][Full Text] [Related]
2. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
Festag M; Viertel B; Steinberg P; Sehner C
Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
[TBL] [Abstract][Full Text] [Related]
3. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test.
Seiler A; Visan A; Buesen R; Genschow E; Spielmann H
Reprod Toxicol; 2004; 18(2):231-40. PubMed ID: 15019721
[TBL] [Abstract][Full Text] [Related]
4. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
Stummann TC; Hareng L; Bremer S
Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
[TBL] [Abstract][Full Text] [Related]
5. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
[TBL] [Abstract][Full Text] [Related]
6. Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds.
zur Nieden NI; Kempka G; Ahr HJ
Toxicol Appl Pharmacol; 2004 Feb; 194(3):257-69. PubMed ID: 14761682
[TBL] [Abstract][Full Text] [Related]
7. Early embryonic sensitivity to cyclophosphamide in cardiac differentiation from human embryonic stem cells.
Zhu MX; Zhao JY; Chen GA; Guan L
Cell Biol Int; 2011 Sep; 35(9):927-38. PubMed ID: 21561436
[TBL] [Abstract][Full Text] [Related]
8. Comparing three novel endpoints for developmental osteotoxicity in the embryonic stem cell test.
zur Nieden NI; Davis LA; Rancourt DE
Toxicol Appl Pharmacol; 2010 Sep; 247(2):91-7. PubMed ID: 20576515
[TBL] [Abstract][Full Text] [Related]
9. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
Kuske B; Pulyanina PY; zur Nieden NI
Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
[TBL] [Abstract][Full Text] [Related]
10. Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.
Pal R; Mamidi MK; Das AK; Bhonde R
J Cell Physiol; 2011 Jun; 226(6):1583-95. PubMed ID: 20945368
[TBL] [Abstract][Full Text] [Related]
11. Monolayer cultivation of osteoprogenitors shortens duration of the embryonic stem cell test while reliably predicting developmental osteotoxicity.
zur Nieden NI; Davis LA; Rancourt DE
Toxicology; 2010 Nov; 277(1-3):66-73. PubMed ID: 20817070
[TBL] [Abstract][Full Text] [Related]
12. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.
van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
Toxicol Sci; 2011 Jan; 119(1):126-34. PubMed ID: 20935163
[TBL] [Abstract][Full Text] [Related]
14. Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro.
Buesen R; Genschow E; Slawik B; Visan A; Spielmann H; Luch A; Seiler A
Toxicol Sci; 2009 Apr; 108(2):389-400. PubMed ID: 19168572
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.
Suzuki N; Ando S; Yamashita N; Horie N; Saito K
Toxicol Sci; 2011 Dec; 124(2):460-71. PubMed ID: 21964422
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.
Peters AK; Steemans M; Hansen E; Mesens N; Verheyen GR; Vanparys P
Toxicol Sci; 2008 Oct; 105(2):342-50. PubMed ID: 18593728
[TBL] [Abstract][Full Text] [Related]
17. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
Louisse J; Gönen S; Rietjens IM; Verwei M
Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
[TBL] [Abstract][Full Text] [Related]
18. Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity.
Peters AK; Wouwer GV; Weyn B; Verheyen GR; Vanparys P; Gompel JV
Toxicol In Vitro; 2008 Dec; 22(8):1948-56. PubMed ID: 18845236
[TBL] [Abstract][Full Text] [Related]
19. Trends in improving the embryonic stem cell test (EST): an overview.
Buesen R; Visan A; Genschow E; Slawik B; Spielmann H; Seiler A
ALTEX; 2004; 21(1):15-22. PubMed ID: 14976585
[TBL] [Abstract][Full Text] [Related]
20. Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines.
Pekkanen-Mattila M; Kerkelä E; Tanskanen JM; Pietilä M; Pelto-Huikko M; Hyttinen J; Skottman H; Suuronen R; Aalto-Setälä K
Ann Med; 2009; 41(5):360-70. PubMed ID: 19165643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
